Cigna Stock in Focus as Investor Day Spotlights Specialty Drugs — Barrons.com
By Catherine DunnWhen Cigna Group holds its first investor day under new CEO Brian Evanko on Wednesday, Wall Street will be looking beyond its insurance business for updates on a key growth area: specialty drugs for patients with cancer and other complex conditions.It's an area that produced strong…